Connect with us

Hi, what are you looking for?

Stock

Here are Stifel’s best small and mid cap UK stocks for 2025

Investing.com — Stifel analysts highlighted their top small and mid-cap UK stock picks for 2025, focusing on sectors such as industrials, healthcare, and technology.

Industrials: AB Dynamics
AB Dynamics stands out as Stifel’s top small-cap pick in the industrials sector. The firm said the company is poised to triple its profit in the next 3-5 years due to its significant investments in operations and infrastructure. 

Stifel notes the potential for “sharply rising margins and strong cash flow” driven by “rising globalising ADAS regulation” and ongoing M&A activities. The analysts believe that the company’s shares could more than double if medium-term goals are achieved.

Healthcare: Hikma Pharmaceuticals (OTC:HKMPY)
In healthcare, Hikma Pharmaceuticals is noted for its diversified operations across injectables, branded, and generics. The injectables segment, particularly in the US, contributes significantly to the company’s EBIT, while the branded division leads in the MENA region. Stifel highlights the company’s focus on complex generics and specialty products, predicting steady growth across its divisions.

Technology: Kainos
Kainos is Stifel’s top technology pick, benefiting from its positioning in government digital transformation and its strong partnership with Workday (NASDAQ:WDAY). The company’s focus on high-margin Workday products and a stable business model with good cash generation are seen as underpinning its growth prospects. Stifel anticipates a healthy backlog and further business wins, supported by the return of CEO Brendan Mooney.

Metals & Mining: Endeavour Mining
Endeavour Mining is highlighted for its diversified portfolio of low-cost, long-life mines in West Africa. Stifel expects strong free cash flow to reduce net debt and support shareholder returns. The company’s sector-leading margins and discovery costs make it an attractive investment for 2025.

Other names that made the list include Melrose (LON:MRON) due to its strong profitability and incoming inflection, Animalcare, based on its Randlab acquisition enhancing its growth prospects, and Persimmon (LON:PSN) as “housebuilders offer “compelling risk/reward here.”

Mondi (LON:MNDI), Restore, Kitwave, Future, Ashtead (LON:AHT) Tech, and Assura were other names highlighted by the firm.

 

This post appeared first on investing.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

    Economy

    LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

    Editor's Pick

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 beneficialinvestmentnow.com